pros and cons of glp-1 agonist The cardiovascular effects receptor agonists beyond obesity type 2 diabetes: An anti-atherosclerotic action Exploring the Side Effects of
Description
Shaikh H., Bradhurst P., Ma L
DozioEVianelloEMalavazosAETacchiniLSchmitzGIacobellisGet alEpicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk
CD36 promotes adipocyte differentiation and adipogenesis
Sanyal et al
Are there specific clinical criteria required for approval (e.g., BMI thresholds, sustained weight requirements, step therapy such as participation in a weight management program)
